Madiha Derouazi

Hoofd Techniek/Wetenschap/O&O bij AC IMMUNE SA

Vermogen: 7 271 $ op 30-04-2024

51 jaar

Health Technology

Consumer Services

Actieve functies van Madiha Derouazi

Bedrijven	Functie	Begin	Einde
AC IMMUNE SA	Hoofd Techniek/Wetenschap/O&O	01-01-2024	-
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.	Directeur/Bestuurslid	03-09-2012	-
	Algemeen Directeur	03-09-2012	-
	Oprichter	03-09-2012	-

Bedrijven	Functie	Begin	Einde

Technical University of Berlin	Graduate Degree
Swiss Federal Institute of Technology	Doctorate Degree

Internationaal

Zwitserland	3
Duitsland	3

Operationeel

Sectoraal

Health Technology	3
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
AC IMMUNE SA	Health Technology

Bedrijven in privébezit	1
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.	Health Technology

Bedrijven in privébezit

Health Technology